Aug. 25, 2022 Price forecast | 2 weeks: -1.12% | 1 month: -1.49% | 3 months: -7.84%


AXDX stock forecast

Our latest prediction for Accelerate Diagnostics Inc's stock price was made on the Aug. 25, 2022 when the stock price was at 1.70$.

In the short term (2weeks), AXDX's stock price should underperform the market by -1.12%. During that period the price should oscillate between -11.12% and +14.22%.

In the medium term (3months), AXDX's stock price should underperform the market by -7.84%. During that period the price should oscillate between -24.30% and +20.85%.

Create a solid portfolio with AXDX

Add AXDX to your portfolio and optimize it!


About Accelerate Diagnostics Inc

accelerate diagnostics, inc. (nasdaq:axdx), is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. the company's revolutionary id/ast platform utilizes a proprietary process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity. in addition to the id/ast development pipeline, the company also owns and licenses its proprietary optichem™ surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays.

At the moment the company generates 8M USD in revenues.

On its last earning announcement, the company reported a loss of -0.80$ per share.

The book value per share is 1.75$

Accelerate Diagnostics Inc website


Three months stock forecastAug. 25, 2022


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
8M 33.80% -51M -592.81% -53M -0.80 - - 79M 1.75 - - -